Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

Type 1 papillary kidney cancer. Hereditary papillary renal carcinoma (HPRC) is an autosomal dominant hereditary cancer syndrome (D) in which affected individuals are at risk for the development of bilateral kidney cancer (A,B) that is type 1 papillary histologic type (C). Patients affected with HPRC are characterized by germline mutation of the MET gene. MET mutations are also found in a subset of tumors (13%) from patients with sporadic, nonhereditary papillary kidney cancer. (Fig. 3 from Linehan et al. 2003.)

This Article

  1. Genome Res. 22: 2089-2100

Preprint Server